Evidence map›Paper›PMID 30275535›Full record

ArticleCellular & molecular immunology2018

E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Zhenlu Chong, Chunjing Bao, Jia He, Tianxiao Chen, Lijia Zhong, Gaopeng Li, Huanle Li, Lutong Fang, Yinjing Song, Guoxiang Fu and 4 more

Abstract read
In one paragraph

Article in Cellular & molecular immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Neddylation Regulation of Immune Responses.Research (Washington, D.C.) · 2023
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhenlu ChongInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Chunjing BaoInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Jia HeInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Tianxiao ChenInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Lijia ZhongThe Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Gaopeng LiInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Huanle LiInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Lutong FangInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Yinjing SongInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Guoxiang FuSir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
Xuyan YangDepartment of Rheumatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Lihua LaiInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
Yang LiuInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China. liuyang0620@zju.edu.cn.
Qingqing WangInstitute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China. wqq@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, and the pathogenesis of SLE has not been fully elucidated. The E3 ubiquitin ligase FBXW7 has been well characterized in cancer as a tumor suppressor that can promote the ubiquitination and subsequent degradation of various oncoproteins; however, the potential role of FBXW7 in autoimmune diseases is unclear. In the present study, we identified that FBXW7 is a crucial exacerbating factor for SLE development and progression in a mouse model induced by 2, 6, 10, 14-tetramethylpentadecane (TMPD). Myeloid cell-specific FBXW7-deficient (Lysm

Indexed as

AnimalsAntigen-Antibody ComplexApoptosisCD11b AntigenDisease Models, AnimalF-Box-WD Repeat-Containing Protein 7HumansKidneyLupus Erythematosus, SystemicMiceMice, Inbred C57BLMice, KnockoutMyeloid Cell Leukemia Sequence 1 ProteinPicolinesProteolysis1-(3-picolinium)-12-triethylammonium-dodecane dibromideAntigen-Antibody ComplexCD11b AntigenF-Box-WD Repeat-Containing Protein 7Mcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 ProteinPicolinesapoptosisFBXW7MCL1Systemic lupus erythematosusubiquitination

Identifiers

PMID30275535
PMCPMC6269436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.